Maintenance fees coming due
6 maintenance fees come due in the 12 months from Nov 15, 2026, the next on Jan 7, 2027. Unpaid by Jul 7, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 9,072,786 | Method of Manufacturing an Implantable Device In force Fee due Jan 7, 2027 Lapses if unpaid Jul 7, 2027 · High confidence | Endo Operations Limited | In force | Jan 7, 2027 | Jul 7, 2027 | High confidence | |
| US 9,090,649 | Oligonucleotide Duplexes Comprising DNA-Like and RNA-Like Nucleotides and Uses Thereof In force Fee due Jan 28, 2027 Lapses if unpaid Jul 28, 2027 · High confidence | Endo Operations Limited | In force | Jan 28, 2027 | Jul 28, 2027 | High confidence | |
| US 9,120,249 | Implant Device Release Agents and Methods of Using Same In force Fee due Mar 1, 2027 Lapses if unpaid Sep 1, 2027 · Medium confidence | Endo Operations Limited | In force | Mar 1, 2027 | Sep 1, 2027 | Medium confidence | |
| US 9,149,351 | Apparatus and Method for Repairing Vaginal Reconstruction In force Fee due Apr 6, 2027 Lapses if unpaid Oct 6, 2027 · Medium confidence | Endo Operations Limited | In force | Apr 6, 2027 | Oct 6, 2027 | Medium confidence | |
| US 11,813,347 | Method of Assessing and Treating Cellulite In force Fee due May 14, 2027 Lapses if unpaid Nov 15, 2027 · Medium confidence | Endo Operations Limited | In force | May 14, 2027 | Nov 15, 2027 | Medium confidence | |
| US 9,186,374 | Vitamin B12 Nasal Spray and Method of Use In force Fee due May 17, 2027 Lapses if unpaid Nov 17, 2027 · Medium confidence | Endo Operations Limited | In force | May 17, 2027 | Nov 17, 2027 | Medium confidence |
6 of 6 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.